drugset / Trial / NCT05896683
A Study of Lazertinib (JNJ-73841937) Tablet in Healthy Adult Participants
RandomizedSequentialOpen-labelBasic science
Summary
The purpose of this study is to assess the extent of availability of drug to the body of four different lazertinib tablet formulations at a single oral dose under fasted conditions in healthy adult participants.
Timeline
- Start
- 2023-05-30
- Primary completion
- 2023-09-01
- Completion
- 2023-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lazertinib | Small molecule | — | Oral |
Indications
No indication recorded.